Organic Letters
Letter
Scheme 2) and o-QM generation which, in the presence of
pyrrolidine, would undergo Michael addition followed by
intramolecular 5-exo-tet elimination of the bromide anion, to
afford 7a. To our surprise, this reaction instead of giving solely
7a, a second product, 1-(5-chloro-2,3-dihydro-1-benzofuran-3-
yl)pyrrolidine 8, was also isolated (Scheme 3). In the first
phenoxide anion intermediate undergoes conjugate elimination
of a nitrate anion.
ASSOCIATED CONTENT
* Supporting Information
■
S
Experimental procedures for all reactions and characterization
data for all new compounds. This material is available free of
Scheme 3. Synthesis of 1-(2,3-Dihydrobenzofuran-3-yl)-
pyrrolidine 7a and Its 5-Chloro Derivative 8 from [2-(2-
Bromo-1-chloroethyl)phenoxy](triisopropyl)silane 5
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the State Scholarship Foundation (I.K.Y.) of Greece
(for a studentship to A. K. S., Grant No. 1210) for support. We
appreciate the use of NMR and mass spectrometry facilities
funded by the Network of Research Supporting Laboratories of
the University of Ioannina and thank Dr. K. Tsiafoulis, and Dr.
V. Kontogianni, Dr. S. Papas, and Dr. A. Karkabounas, of the
University of Ioannina, for 2D NMR spectra and mass spectra,
respectively. We thank Dr. A. J. A. Cobb of the University of
Reading for the HRMS spectrum of compound 4.
experiment at −78 °C, 7a and 8 were isolated by SiO2 column
chromatography in 5% and 2% yield, respectively. When the
reaction was repeated at 0 °C followed by stirring at rt for 40
min, 7a and 8 were isolated by column chromatography in 10%
and 5% yield, respectively. At present we are not in a position
to suggest a plausible ionic or radical mechanism for the
formation of 8. Repeating this reaction and using instead of
THF and pyrrolidine either MeOH or 2-PrOH, to act as both
solvents and nucleophiles at 0 °C, afforded compounds 7d and
7e in only 12% and 8% yields, respectively (Scheme 4). No
chlorination products were detected in these two reactions.
REFERENCES
■
(1) Iwahashi, M.; Shimabukuro, A.; Onoda, T.; Matsunaga, Y.;
Okada, Y.; Matsumoto, R.; Nambu, F.; Nakai, H.; Toda, M. Bioorg.
Med. Chem. 2011, 19, 4574−4588.
(2) For examples, see: (a) Keay, B. A.; Hopkins, J. M.; Dibble, P. W.
In Comprehensive Heterocyclic Chemistry III; Katritzky, A. R., Ramsden,
C. A., Scriven, E. F. V., Taylor, R. J. K., Eds.; Elsevier Science, Ltd.:
Oxford, 2008; Vol. 3 (Gurnos, J., Christopher, A. R., Eds.), pp 1225−
1241. (b) Bertolini, F.; Pineschi, M. Org. Prep. Proced. Int. 2009, 41,
385−418. (c) Chin, E.; Li, J.; Talamas, F. X.; Wang, B. (F. Hoffmann-
La Roche A.G.). Pyrine or Pyrazine Derivatives for Treating HCV.
WO Patent 2010034671, April 1, 2010. (d) Pettersson, M.; Johnson,
D. S.; Subramanyam, C.; Bales, K. R.; am Ende, C. W.; Fish, B. A.;
Green, M. E.; Kauffman, G. W.; Lira, R.; Mullins, P. B.; Navaratnam,
T.; Sakya, S. M.; Stiff, C. M.; Tran, T. P.; Vetelino, B. C.; Xie, L.;
Zhang, L.; Pustilnik, L. R.; Wood, K. M.; O’Donnell, C. J. Bioorg. Med.
Chem. Lett. 2012, 22, 2906−2911. (e) Zeng, X.; Wang, Y.; Qiu, Q.;
Jiang, C.; Jing, Y.; Qiu, G.; He, X. Fitoterapia 2012, 83, 104−109.
(f) Reuter, K. C.; Grunwitz, C. R.; Kaminski, B. M.; Steinhilber, D.;
Radeke, H. H.; Stein, J. J. Pharmacol. Exp. Ther. 2012, 341, 68−80.
(g) Chol, S.; Song, K.-S.; Lee, S. H.; Kim, M. J.; Seo, H. J.; Park, E.-J.;
Kong, Y.; Park, S. O.; Kang, H.; Jung, M. E.; Lee, K.; Kim, H. J.; Lee, J.
S.; Lee, M. W.; Kim, M.-S.; Hong, D. H.; Kang, M. (Green Cross
Corp.). Novel Diphenylmethane Derivatives as SGLT2 Inhibitors.
WO Patent 2012165914, Dec. 6, 2012. (h) Cheng, Y.; Hu, X.-Q.; Gao,
S.; Lu, L.-Q.; Chen, J.-R.; Xiao, W.-J. Tetrahedron 2013, 69, 3810−
3816.
Scheme 4. Synthesis of 3-Methoxy (or Isopropoxy)-2,3-
dihydrobenzofurans 7d,e from [2-(2-Bromo-1-chloro-
ethyl)phenoxy](triisopropyl)silane 5
(3) (a) Hasegawa, E.; Hirose, H.; Sasaki, K.; Takizawa, S.; Seida, T.;
Chiba, N. Heterocycles 2009, 77, 1147−1161. (b) Dickschat, A.; Studer,
A. Org. Lett. 2010, 12, 3972−3974. (c) Nomoto, A.; Kojo, Y.; Shiino,
G.; Tomisaka, Y.; Mitani, I.; Tatsumi, M.; Ogawa, A. Tetrahedron Lett.
In conclusion, we have presented a new one-pot regio-
selective synthesis of 3-substituted 2,3-dihydrobenzofurans
from 2-bromo-1-{2-[(triisopropylsilyl)oxy]phenyl}ethyl nitrate
via o-QM generation in situ and Michael addition of different C,
N, O, and S nucleophiles to give a phenoxide anion
intermediate which undergoes intramolecular 5-exo-tet elimi-
nation of a bromide anion. o-QM is formed from the nitrate
ester by a fluoride anion nucleophilic cleavage of the silyloxy σ-
bond using n-tetrabutylammonium fluoride whereby the
́
2010, 51, 6580−6583. (d) Rouquet, G.; Robert, F.; Mereau, R.; Castet,
F.; Landais, Y. Chem.Eur. J. 2011, 17, 13904−13911. (e) Lockner, J.
W.; Dixon, D. D.; Risgaard, R.; Baran, P. S. Org. Lett. 2011, 13, 5628−
5631. (f) Hisanori, S.; Jun-ya, M.; Shoji, H. Synlett 2011, 1567−1572.
(g) Mitsudo, K.; Nakagawa, Y.; Mizukawa, J.-i.; Tanaka, H.; Akaba, R.;
Okada, T.; Suga, S. Electrochim. Acta 2012, 82, 444−449. (h) Pan, X.;
̂ ́
Lacote, E.; Lalevee, J.; Curran, D. P. J. Am. Chem. Soc. 2012, 134,
5669−5674. (i) Nguyen, J. D.; D’Amato, E. M.; Narayanam, J. M. R.;
1480
dx.doi.org/10.1021/ol500290e | Org. Lett. 2014, 16, 1478−1481